Exacerbations in COPD patients treated with Inhaled Corticosteroids/Long-acting β2 agonists combinations, switching to another combination drugs or inhaler device: A “real – world” study

Exacerbations in COPD patients treated with Inhaled Corticosteroids/Long-acting β2 agonists combinations, switching to another combination drugs or inhaler device: A “real – world” study

This study investigates the effects of switching to different devices of the same active substance or between different active substances, in patients with Chronic Obstructive Pulmonary Disease (COPD) treated with Inhaled Corticosteroids (ICS) plus Long-acting β2-adrenergic agonists (LABAs) in terms...

Full description

Bibliographic Details
Main Authors: Diego Sangiorgi, Valentina Perrone, Stefano Buda, Luca Degli Esposti
Format: Article
Language:English
Published: Taylor & Francis Group 2017-01-01
Series:Cogent Medicine
Subjects:
chronic obstructive pulmonary disease
exacerbations
inhaled corticosteroids
long-acting β2-agonist
switching therapy
Online Access:http://dx.doi.org/10.1080/2331205X.2017.1304873

Internet

http://dx.doi.org/10.1080/2331205X.2017.1304873

Similar Items